/PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing.
Willow Continues its Transition to the Bay Area in California with Management Promotions and a New Board Member
MOUNTAIN VIEW, Calif. , March 28, 2023 /PRNewswire/ - Willow Biosciences Inc. (
/PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing.
Willow Biosciences Reports First Quarter 2021 Results, an Operational Update and the Addition of a New Board Member
News provided by
Share this article
Willow or the
Company ) (TSX: WLLW) (OTCQX: CANSF) has released its financial and operating results for the three months ended March 31, 2021, reporting significant advancement in its operations and strong liquidity. The first quarter represented another significant move forward for us, as we completed our first commercial scale fermentation run and strengthened our balance sheet for success, said Trevor Peters, Willow s President and Chief Executive Officer. We are entering the next phase for the Company, which is creating new markets for our ultra-pure, sustainably made, cannabinoids, and our world class team has allowed us to be at the forefront of the industry. As the industry continues to move towards increased regulation from a health and safety perspective, there is a need now more than ever for Willow s consistent